Page
%P
-
Article
Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation
To determine the efficacy and toxicities of sorafenib in the treatment of patients with multiple recurrences of hepatocellular carcinoma (HCC) after liver transplantation in a Chinese population.